Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
21.50
-0.61 (-2.76%)
Dec 5, 2025, 4:00 PM EST - Market closed
Tyra Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -111.68 | -86.48 | -69.13 | -55.33 | -26.29 | -9.34 | |
| Depreciation & Amortization | 0.56 | 0.52 | 0.36 | 0.3 | 0.14 | 0.05 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0 | 0 | 0 | |
| Loss (Gain) From Sale of Investments | -3.18 | -5.88 | -1.25 | - | - | - | |
| Stock-Based Compensation | 27.08 | 22.8 | 13.53 | 10.59 | 2.89 | 0.44 | |
| Other Operating Activities | - | - | - | - | - | 0.02 | |
| Change in Accounts Payable | 3.42 | -0.74 | 9.37 | 2.36 | 1.49 | 1.02 | |
| Change in Other Net Operating Assets | -7.31 | 0.02 | -3.01 | -8.2 | -1.97 | 0.05 | |
| Operating Cash Flow | -91.11 | -69.77 | -50.14 | -50.29 | -23.75 | -7.76 | |
| Capital Expenditures | -0.09 | -0.66 | -0.77 | -0.56 | -0.66 | -0.31 | |
| Sale of Property, Plant & Equipment | - | - | - | - | 0.02 | - | |
| Investment in Securities | 45.13 | -97.74 | -143.84 | - | - | - | |
| Investing Cash Flow | 45.04 | -98.4 | -144.61 | -0.56 | -0.65 | -0.31 | |
| Long-Term Debt Repaid | - | - | - | - | -0.01 | -0.02 | |
| Net Debt Issued (Repaid) | - | - | - | - | -0.01 | -0.02 | |
| Issuance of Common Stock | 4.12 | 202.56 | 1.54 | 0.63 | 181.73 | 0.14 | |
| Other Financing Activities | - | -0.42 | - | - | - | - | |
| Financing Cash Flow | 4.12 | 202.14 | 1.54 | 0.63 | 311.35 | 23.43 | |
| Net Cash Flow | -41.94 | 33.96 | -193.21 | -50.21 | 286.96 | 15.36 | |
| Free Cash Flow | -91.2 | -70.44 | -50.91 | -50.84 | -24.41 | -8.08 | |
| Free Cash Flow Per Share | -1.53 | -1.23 | -1.19 | -1.21 | -1.77 | -5.24 | |
| Cash Interest Paid | - | - | - | - | 1.24 | 0 | |
| Levered Free Cash Flow | -48.56 | -41.15 | -29.49 | -28.56 | -14.18 | -8.98 | |
| Unlevered Free Cash Flow | -48.56 | -41.15 | -29.49 | -28.56 | -14.18 | -8.97 | |
| Change in Working Capital | -3.89 | -0.73 | 6.36 | -5.85 | -0.48 | 1.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.